NUBLAXON

Table of contents:

Trademark domain
nameis free?
nublaxon.com

The "NUBLAXON" trademark, serial number 78669142 , was filed on 13th of July 2005 with a mark drawing code of 4000 and its transaction date is 78669142. The attorney assigned is Maury M. Tepper, III, attorney docket number 51653. Since 31st of December 2009, the document can be found in the M40 law office in the publication and issue section. The employee responsible is DAHLING, KRISTIN M and the date it was published for opposition on 04/04/2006. The status of this trademark was checked last on 07/27/2009.

Other trademarks by this attorney include , DIGGER, EL DERMATOFITO , DIGGER, EL DERMATOFITO . The corresponded responsible for this trademark is Maury M. Tepper, III, located at Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh NC 27609.

The state or country where the trademark was organized is by Novartis Ag. The legal entity type behing it is a Corporation, located at 4002, Basel, zip .Other trademarks by this applicant: NOBLEXA, NUBLOSSENT, NUBLOXIN.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date07/19/2005
Primary Code005
Goods codes
GS0051Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacteria-based diseases, antivirals, anti-biotics, anti-fungals
PROSECUTION HISTORY
DateDescriptionTypeCode
07/27/2009 ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED O - Outgoing Correspondence MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
07/27/2009 ABANDONMENT - NO USE STATEMENT FILED S ABN6 - ABANDONMENT - NO USE STATEMENT FILED
06/19/2009 TEAS CHANGE OF CORRESPONDENCE RECEIVED I - Incoming Correspondence TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/16/2008 EXTENSION 5 GRANTED S EX5G - EXTENSION 5 GRANTED
12/16/2008 EXTENSION 5 FILED S EXT5 - EXTENSION 5 FILED
12/16/2008 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
06/16/2008 EXTENSION 4 GRANTED S EX4G - EXTENSION 4 GRANTED
06/16/2008 EXTENSION 4 FILED S EXT4 - EXTENSION 4 FILED
06/16/2008 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
12/17/2007 EXTENSION 3 GRANTED S EX3G - EXTENSION 3 GRANTED
12/17/2007 EXTENSION 3 FILED S EXT3 - EXTENSION 3 FILED
12/17/2007 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
06/25/2007 EXTENSION 2 GRANTED S EX2G - EXTENSION 2 GRANTED
06/25/2007 EXTENSION 2 FILED S EXT2 - EXTENSION 2 FILED
06/25/2007 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
12/06/2006 EXTENSION 1 GRANTED S EX1G - EXTENSION 1 GRANTED
12/06/2006 EXTENSION 1 FILED S EXT1 - EXTENSION 1 FILED
12/06/2006 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
06/27/2006 NOA MAILED - SOU REQUIRED FROM APPLICANT O - Outgoing Correspondence NOAM - NOTICE OF ALLOWANCE-MAILED
06/19/2006 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
04/04/2006 PUBLISHED FOR OPPOSITION A - Allowance for Publication PUBO - PUBLISHED FOR OPPOSITION
03/15/2006 NOTICE OF PUBLICATION O - Outgoing Correspondence NPUB - NOTICE OF PUBLICATION
02/15/2006 LAW OFFICE PUBLICATION REVIEW COMPLETED O - Outgoing Correspondence PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2006 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
02/02/2006 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2006 EXAMINERS AMENDMENT E-MAILED F - First Action GNEA - EXAMINERS AMENDMENT E-MAILED
02/02/2006 EXAMINERS AMENDMENT -WRITTEN R - Renewal CNEA - EXAMINERS AMENDMENT -WRITTEN
02/02/2006 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
11/16/2005 TEAS CHANGE OF CORRESPONDENCE RECEIVED I - Incoming Correspondence TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/19/2005 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM

The "NUBLAXON" trademark, serial number 77768177 , was filed on 25th of June 2009 with a mark drawing code of 4000 and its transaction date is 77768177. The attorney assigned is Maury M. Tepper, III, attorney docket number . Since 31st of March 2010, the document can be found in the L30 law office in the publication and issue section. The employee responsible is KIM, JANICE and the date it was published for opposition on 09/29/2009. The date when we last checked the status of this trademark was 12/22/2009.

Other trademarks by this attorney include , NOBLEXA , NUBLOXIN , NUBLOSSENT . The corresponded responsible for this trademark is MAURY M. TEPPER, III, located at TEPPER & EYSTER, PLLC, 3724 BENSON DR, RALEIGH, NC 27609-7321.

The state or country where the trademark was organized is by Novartis Ag. The legal entity type behing it is a Corporation, located at Ch-4002, Basel, zip .

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date06/29/2009
Primary Code005
Goods codes
GS0051Anti-infectives; Antibiotics; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes
PROSECUTION HISTORY
DateDescriptionTypeCode
12/22/2009 NOA MAILED - SOU REQUIRED FROM APPLICANT O - Outgoing Correspondence NOAM - NOTICE OF ALLOWANCE-MAILED
09/29/2009 PUBLISHED FOR OPPOSITION A - Allowance for Publication PUBO - PUBLISHED FOR OPPOSITION
09/09/2009 NOTICE OF PUBLICATION O - Outgoing Correspondence NPUB - NOTICE OF PUBLICATION
08/24/2009 LAW OFFICE PUBLICATION REVIEW COMPLETED O - Outgoing Correspondence PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
08/24/2009 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
08/19/2009 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
08/18/2009 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
06/29/2009 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I - Incoming Correspondence NWOS
06/29/2009 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM


Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.